These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 8826855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J, Davies R, Malkhandi J, Gant TW, Ferry DR, Gescher A.
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [Abstract] [Full Text] [Related]

  • 3. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F.
    J Biol Chem; 1991 Aug 25; 266(24):15771-81. PubMed ID: 1874734
    [Abstract] [Full Text] [Related]

  • 4. The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance.
    Gekeler V, Boer R, Ise W, Sanders KH, Schächtele C, Beck J.
    Biochem Biophys Res Commun; 1995 Jan 05; 206(1):119-26. PubMed ID: 7818510
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.
    Gill PK, Gescher A, Gant TW.
    Eur J Biochem; 2001 Aug 05; 268(15):4151-7. PubMed ID: 11488907
    [Abstract] [Full Text] [Related]

  • 7. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.
    Merritt JE, Sullivan JA, Drew L, Khan A, Wilson K, Mulqueen M, Harris W, Bradshaw D, Hill CH, Rumsby M, Warr R.
    Cancer Chemother Pharmacol; 1999 Aug 05; 43(5):371-8. PubMed ID: 10100591
    [Abstract] [Full Text] [Related]

  • 8. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
    Le Panse R, Coulomb B, Mitev V, Bouchard B, Lebreton C, Dubertret L.
    Mol Pharmacol; 1994 Sep 05; 46(3):445-51. PubMed ID: 7935324
    [Abstract] [Full Text] [Related]

  • 9. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
    Gupta KP, Ward NE, Gravitt KR, Bergman PJ, O'Brian CA.
    J Biol Chem; 1996 Jan 26; 271(4):2102-11. PubMed ID: 8567666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
    Wang Q, Worland PJ, Clark JL, Carlson BA, Sausville EA.
    Cell Growth Differ; 1995 Aug 26; 6(8):927-36. PubMed ID: 8547221
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells.
    Wielinga PR, Heijn M, Broxterman HJ, Lankelma J.
    Biochem Pharmacol; 1997 Oct 01; 54(7):791-9. PubMed ID: 9353133
    [Abstract] [Full Text] [Related]

  • 16. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.
    Patterson KK, Beckman BS, Klotz DM, Mallia CM, Jeter JR.
    J Cancer Res Clin Oncol; 1996 Oct 01; 122(8):465-75. PubMed ID: 8698746
    [Abstract] [Full Text] [Related]

  • 17. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
    Cloud-Heflin BA, McMasters RA, Osborn MT, Chambers TC.
    Eur J Biochem; 1996 Aug 01; 239(3):796-804. PubMed ID: 8774728
    [Abstract] [Full Text] [Related]

  • 18. Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts.
    Uberall F, Giselbrecht S, Hellbert K, Fresser F, Bauer B, Gschwendt M, Grunicke HH, Baier G.
    J Biol Chem; 1997 Feb 14; 272(7):4072-8. PubMed ID: 9020116
    [Abstract] [Full Text] [Related]

  • 19. Selected isozymes of PKC contribute to augmented growth of fetal and neonatal bovine PA adventitial fibroblasts.
    Das M, Stenmark KR, Ruff LJ, Dempsey EC.
    Am J Physiol; 1997 Dec 14; 273(6):L1276-84. PubMed ID: 9435584
    [Abstract] [Full Text] [Related]

  • 20. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
    Spitaler M, Utz I, Hilbe W, Hofmann J, Grunicke HH.
    Biochem Pharmacol; 1998 Oct 01; 56(7):861-9. PubMed ID: 9774148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.